Rizatriptan does not change cerebral blood flow velocity during migraine attacks

Brain Research Bulletin

Volumn 65, Issue 4, 2005, Pages 297-300

  Gori, S ^a   Morelli, N ^a   Bellini, G ^a   Bonanni, E ^a   Manca, L ^a   Orlandi, G ^a   Iudice, A ^a   Murri, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Migraine; Rizatriptan; Transcranial Doppler

Indexed keywords

ANTIMIGRAINE AGENT; RIZATRIPTAN; SEROTONIN AGONIST; TRIAZOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; MIGRAINE; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; BLOOD; BLOOD FLOW; BRAIN CORTEX; CLINICAL TRIAL; COMPARATIVE STUDY; HEMISPHERIC DOMINANCE; LASER DOPPLER FLOWMETRY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADULT; CEREBRAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MIGRAINE DISORDERS; REGIONAL BLOOD FLOW; SEROTONIN AGONISTS; TIME FACTORS; TRIAZOLES; TRYPTAMINES;

EID: 20344379711     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2004.10.015     Document Type: Article

References (28)

1. H. Baezner, W. Steinke, M. Daffertshofer, and M. Henneirci Vasoneuronal coupling in migraineurs after subcutaneous sumatriptan: a TCD study J. Neurol. Sci. 167 1999 50 55
2. M.G. Bousser, J. Conard, S. Kittner, B. de Lignieres, E.A. MacGregor, H. Massiou, S.D. Silberstein, and C. Tzourio Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task force on Combined Oral Contraceptives and Hormone Replacement Therapy Cephalalgia 20 2000 155 156
3. J.F. Caekebeke, M.D. Ferrari, C.P. Zwetslott, J. Jansen, and P.R. Saxena Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks Neurology 42 1992 1522 1526
4. A. Carolei, C. Marini, and G. De Matteis History of migraine and risk of cerebral ischaemia in young adults Lancet 347 1996 1503 1506
5. J.E. Cavazos, J.B. Carres, and V.R. Chilikuri Sumatriptan-induced stroke in sagittal sinus thrombosis Lancet 343 1994 1105 1106
6. C.L. Chang, M. Donaghy, and N. Poulter Migraine and stroke in young women: case-control study, The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception BMJ 318 1999 13 18
7. P.C. Combremont, and E.M. Marcus Intracranial hemorrhages associated with sumatriptan Neurology 56 2001 1243 1244
8. J.N. de Honn, J.M. Willigers, J. Troost, H.A. Struijker-Boudier, and L.M. Van Bortel Vascular effect of 5-HT1B/1D-receptor agonist in patients with migraine headaches Clin. Pharmacol. Ther. 68 2000 418 426
9. D. Deleu, and Y. Hanssens Current and emerging second-generation triptans in acute migraine therapy: a comparative review J. Clin. Pharmacol. 40 2000 687 700
10. H.C. Diener, J. Haab, C. Peters, S. Ried, J. Dichgans, and A. Pilgrim Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache Headache 31 1991 205 209
11. H.C. Diener, C. Peters, and M. Rudzio Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subject and migraneurs J. Neurol. 238 1991 245 250
12. M. Donaghy, C.L. Chang, and N. Poulter Duration, frequency, recency and type of migraine and the risk of ischaemic stroke in women of childbearing age J. Neurol. Neurosurg. Psychiatry 73 2002 747 750
13. R.W. Evans, and V. Martin Expert opinion: assessing cardiac risk prior to use of triptans Headache 40 2000 599 602
14. L. Friberg, J. Olesen, H.K. Iverson, and B. Sperling Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan Lancet 338 1991 13 17
15. M.J. Gawel The new triptans Can. J. Clin. Pharmacol. 6 Suppl. A 1999 20A 24A
16. P.J. Goadsby, and R.J. Hargreaves Mechanisms of action of serotonin 5-HT1B/1D agonists: insights into migraine pathophysiology using rizatriptan Neurology 55 2000 S8 S14
17. Headache Classification Committee of the International Headache Society, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia 8 (Suppl. 7) (1988) 1-96.
18. J.E.L. Jayamaha, and M.K. Street Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan Intensive Care Med. 21 1995 82 83
19. S.S. Jhee, T. Shiovitz, A.W. Crawford, and N.R. Cutler Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review Clin. Pharmacokinet. 40 2001 189 205
20. V. Limmroth, A. May, P. Auerbach, G. Wosnitza, T. Eppe, and H.C. Diener Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine J. Neurol. Sci. 138 1996 60 65
21. J. Longmore, Z. Razzaque, and D. Shaw Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors Br. J. Clin. Pharmacol. 46 1998 577 582
22. J.F. Meschia, M.D. Malkoff, and J. Biller Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin Arch. Neurol. 55 1998 714
23. K.I. Roon, A. Maassen Van Den Brink, M.D. Ferrari, and P.R. Saxena Bovine isolated middle cerebral artery contractions to antimigraine drugs Naunyn. Schmiedebergs. Arch. Pharmacol. 360 1999 591 596
24. S.J. Tepper Safety and rational use of the triptans Med. Clin. North. Am. 85 2001 959 970
25. P. Tfelt-Hansen, D. Vries, and P. Saxena Triptans in migraine, a comparative review of pharmacology, pharmacokinetics and efficacy Drugs 60 2000 1259 1287
26. R. Totaro, G. De Matteis, C. Marini, M. Baldassarre, and A. Carolei Sumatriptan and cerebral blood flow velocity changes during migraine attacks Headache 37 1997 635 639
27. C. Tzourio, S.J. Kittner, M.G. Cousser, and A. Alperovitch Migraine and stroke in young women Cephalalgia 20 2000 190 199
28. D.J. Williamson, S.L. Shepheard, R.G. Hill, and R.J. Hargreavers The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation Eur. J. Pharmacol. 328 1997 61 64